Mirvetuximab

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Mirvetuximab

Dec 29, 2024, 10:16 | Insight

Paolo Tarantino: Top 10 ADC Milestones of 2024

Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared on X: “2024 has…

Dec 25, 2024, 16:25 | Blog

Rohit Gosain: Summary of 8 new drugs/indications in Breast Cancer and Gynae Oncology by FDA

Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "2024 approvals: Summary of…

Apr 17, 2024, 11:33 | Drugs

Tanja Obradovic: What can we expect from antibody-drug conjugates (ADCs) in advanced ovarian cancer beyond Mirvetuximab?

Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “What…

Mar 28, 2024, 03:11 | Drugs

Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer

Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post…

Dec 27, 2023, 13:21 | Insight

First data showing overall survival benefit for PARPi maintenance for Ovarian Cancer - ACS Journal Cancer

ACS Journal Cancer posted on X/Twitter: "Just published! 'Top advances of the year: Ovarian Cancer'…

Oct 2, 2023, 18:10 | Insight

Raffaele Colombo: ADC history.

Quoting Raffaele Colombo, Principal Scientists at Zyme Works on X/Twitter: “Maytansine was isolated in the…

All: 6 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023